Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Responses to Influenza Vaccine in Nasal Cells
NCT03023553Phase 4Completed
- Sponsor
- Stanford University
- Start
- Dec 2012
- Primary completion
- Feb 2013
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by Stanford University. Started Dec 2012; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03023553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023553.